Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532).
作者信息
Brookman-May Sabine D, May Matthias
机构信息
Janssen Research and Development Oncology, Los Angeles, CA, USA; Janssen Pharma Research and Development Oncology, Los Angeles, CA, USA.
Department of Urology, St. Elisabeth-Hospital, Straubing, Germany.
出版信息
Eur Urol. 2020 Dec;78(6):930-931. doi: 10.1016/j.eururo.2020.06.014. Epub 2020 Jun 16.
Abstract
摘要
相似文献
1
Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532).回复：前列腺癌的雄激素剥夺疗法与感染严重急性呼吸综合征冠状病毒2的风险：一项基于人群的研究（n = 4532）
Eur Urol. 2020 Dec;78(6):930-931. doi: 10.1016/j.eururo.2020.06.014. Epub 2020 Jun 16.
2
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
3
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. Reply.
J Urol. 2021 Sep;206(3):785. doi: 10.1097/JU.0000000000001884. Epub 2021 May 17.
4
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter.
J Urol. 2021 Sep;206(3):784-785. doi: 10.1097/JU.0000000000001883. Epub 2021 May 17.
5
Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?前列腺癌患者接受雄激素剥夺治疗能预防新型冠状病毒肺炎吗？
Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
6
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.前列腺癌男性患者的雄激素剥夺疗法与严重急性呼吸综合征冠状病毒2：来自加利福尼亚大学卫生系统登记处的研究结果
Ann Oncol. 2021 May;32(5):678-679. doi: 10.1016/j.annonc.2021.01.067. Epub 2021 Feb 8.
7
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.关于前列腺癌雄激素剥夺治疗与严重急性呼吸综合征冠状病毒2感染风险之间的关系。
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
8
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.雄激素剥夺疗法不会影响前列腺癌男性感染 SARS-CoV-2 的风险。
J Urol. 2021 Feb;205(2):441-443. doi: 10.1097/JU.0000000000001338. Epub 2020 Sep 8.
9
Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.雄激素剥夺治疗的前列腺癌患者中 SARS-CoV-2 感染与疾病严重程度的关系：系统评价和荟萃分析。
World J Urol. 2022 Apr;40(4):907-914. doi: 10.1007/s00345-021-03810-6. Epub 2021 Sep 3.
10
Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection.雄激素剥夺疗法与 COVID-19 感染无关。
Prostate. 2023 May;83(6):555-562. doi: 10.1002/pros.24485. Epub 2023 Jan 19.
引用本文的文献
1
Association between prostate cancer and susceptibility, hospitalization, and severity of COVID-19: Based on a Mendelian randomization study.基于孟德尔随机化研究的前列腺癌与 COVID-19 易感性、住院和严重程度的相关性。
Medicine (Baltimore). 2024 Sep 6;103(36):e39430. doi: 10.1097/MD.0000000000039430.
本文引用的文献
1
Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells.血管紧张素转换酶2（ACE2）、严重急性呼吸综合征冠状病毒2（SARS-CoV-2）受体及跨膜丝氨酸蛋白酶2（TMPRSS2）在前列腺上皮细胞中的表达
Eur Urol. 2020 Aug;78(2):296-298. doi: 10.1016/j.eururo.2020.04.065. Epub 2020 May 6.
2
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
3
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染可能由雄激素介导。
J Am Acad Dermatol. 2020 Jul;83(1):308-309. doi: 10.1016/j.jaad.2020.04.032. Epub 2020 Apr 10.
4
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.TMPRSS2 促进冠状病毒感染后小鼠模型呼吸道中的病毒传播和免疫病理。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01815-18. Print 2019 Mar 15.
7
Androgen receptor and androgen-dependent gene expression in lung.肺中的雄激素受体和雄激素依赖性基因表达。
Mol Cell Endocrinol. 2010 Apr 12;317(1-2):14-24. doi: 10.1016/j.mce.2009.12.022. Epub 2009 Dec 24.
8
Dihydrotestosterone inhibits fetal rabbit pulmonary surfactant production.双氢睾酮抑制胎兔肺表面活性物质的产生。
J Clin Invest. 1982 Mar;69(3):611-6. doi: 10.1172/jci110488.
9
Androgen receptors influence the production of pulmonary surfactant in the testicular feminization mouse fetus.雄激素受体影响睾丸女性化小鼠胎儿肺表面活性物质的产生。
J Clin Invest. 1985 Jul;76(1):177-81. doi: 10.1172/JCI111943.
Zotero 插件